ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Grants ODD for Esophageal, Gastroesophageal Junction, Pancreatic Cancer Treatment
October 21, 2020Apexigen announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation status to APX005M for the treatment of esophageal and gastroesophageal junction cancer and for the treatment of pancreatic cancer. -
Quick-fire fundraisings give Apexigen $73M for I-O push
August 09, 2018California biotech Apexigen has raised $73 million from a pair of financings that will be used for clinical testing of its lead CD40-targeting immuno-oncology candidate as well as to broaden its pipeline.
Pharma Sources Insight January 2025
